Biogen Reiterates Byooviz Will Not Be Meaningful In 2022

Launches Outside Of The US Scheduled For Early 2023

Eye
Coherus is set to rival Biogen's Byooviz launch • Source: Shutterstock

More from Archive

More from Generics Bulletin